Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Clinical trial NCT03173937 · RECRUITING

Trial details

NCT number: NCT03173937
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia Hypo-Plastic MDS Myelodysplastic Syndrome (MDS)

Start date: 2017-06-13
Primary completion: 2027-04-28
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.